Skeletal muscle atrophy is defined as a reduction of muscle mass caused by excessive protein degradation. However, the development of therapeutic interventions is still in an early stage. Although glucagon‐like peptide‐1 receptor (GLP‐1R) agonists, such as exendin‐4 (Ex‐4) and dulaglutide, are...
by Beverly M.K. Biller, M.D.
The most interesting feature of cabergoline in terms of patient comphance is its extremely long half-life. Most patientscan be treated with a single weekly dose, is in contrast to the 1-3 times daily administration required for brornocriptine. Particularly in the...
theguerillachemist
A lot of people ask me what are the best legal fat burning supplements. While I still think that nothing rivals the ephedrine/caffeine stack, this compound is probably the best one that’s available in supplement form. Rauwolscine AKA alpha-yomhimbe is a yohimbine isomer that...
N-coumaryoldopamine and N-caffeoyldopamine are 2 very interesting fat-burning compounds. They are both beta-2 agonists(like ephedrine and clenbuterol) and have been shown to dramatically increase production of cyclic AMP(cAMP). Their mechanism of action is very similar to clenbuterol, which many...
Not a fan of secretagogues when you can administer the end result igf-1 directly, however its still one of the better secretagogues among its class and shows elevated igf-1 level in humans with just one dosage for nearly a full day, so below is a quick profile of mk-677 for anyone interested in...
RAD-140 is indeed very interesting.
First, as to terminology. An “agonist” is a molecule which activates a receptor. A full agonist, at high enough concentration in the blood or test medium, can achieve 100% effect from the receptors. A partial agonist, also called a weak agonist, can only...
Q: “You’ve previously written that SARMs such as Ostarine are more hype than reality. They imitate the name of SERMs, claiming to be “Selective Androgen Receptor Modulators” to have a name that might go over better with the public than “anabolic steroids” does. Well you didn’t say exactly that...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.